8-(4-tolylsulfonylamino)quinoline has been researched along with Disease Exacerbation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, JY; Hong, S; Jung, Y; Kim, JH; Kweon, DH; Lee, J; Park, KW; Yang, WS; Yi, YS; Yoo, DS | 1 |
1 other study(ies) available for 8-(4-tolylsulfonylamino)quinoline and Disease Exacerbation
Article | Year |
---|---|
8-(Tosylamino)quinoline inhibits tumour progression through targeting phosphoinositide-3-kinase/Akt pathway.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chorioallantoic Membrane; Disease Progression; Humans; Immunoprecipitation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Neoplasm Invasiveness; Neovascularization, Pathologic; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Quinolines; Tosyl Compounds; Wound Healing | 2013 |